Back to search
FDAFDA · Food and drugs·Recall number D-0390-2016

Carbo-O-Philic 40 Cream 40% (Urea) tubes, a) 3 oz (85 g) (NDC 54162-640-03) , b) 7 oz (200 g) (NDC 54162-640-07), Rx Only For topical use only, Distributed by Geritrex Corporation, East Mount Vernon, NY 10550

Published December 9, 2015 · Recall initiated: October 27, 2015

Summary

FDA records drug Class II recall D-0390-2016, published December 9, 2015 and initiated October 27, 2015. Recalling firm: Geritrex Corp; Status: Terminated; Reported quantity: 9,948 tubes: 3 oz(8,832), 7 oz(1,116); Lot: Lot #: a)1502156, 1507104 b)1503039, 1507001. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Geritrex Corp
Distributor
Nationwide
Lot
Lot #: a)1502156, 1507104 b)1503039, 1507001
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbo-O-Philic 40 Cream 40% (Urea) tubes, a) 3 oz (85 g) (NDC 54162-640-03) , b) 7 oz (200 g) (NDC 54162-640-07), Rx Only For topical use only, Distributed by Geritrex Corporation, East Mount Vernon, NY 10550 recalled?

Yes. FDA published recall D-0390-2016 on December 9, 2015. Reported hazard: Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit